Wyeth Heads To Court Again To Protect Effexor
In the latest chapter in its long-running fight to block generic competition for the popular antidepressant Effexor XR, Wyeth has slapped Orchid Chemicals & Pharmaceuticals Ltd. and subsidiary Orgenus Pharma Inc....To view the full article, register now.
Already a subscriber? Click here to view full article